Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases. Its product candidates are based on the proprietary polymeric nanoparticle construct called CriPec. Additionally, the company provides the CliCr chemistry platform. Cristal Therapeutics serves the nanomedicines, therapeutics, biomaterials, and diagnostics sectors.